JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chow, B. J.W.
Right arrow Articles by Beanlands, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chow, B. J.W.
Right arrow Articles by Beanlands, R. S.
Journal of Nuclear Medicine Vol. 46 No. 7 1095-1101
© 2005 by Society of Nuclear Medicine


Clinical Investigations

Prognostic Significance of Dipyridamole-Induced ST Depression in Patients with Normal 82Rb PET Myocardial Perfusion Imaging

Benjamin J.W. Chow, MD1,2, James W. Wong, BSc1, Keiichiro Yoshinaga, MD1, Terrence D. Ruddy, MD1,2, Kathryn Williams, MS1, Robert A. deKemp, PhD1, Jean DaSilva, PhD1 and Rob S. Beanlands, MD1,2

1 Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada
2 Division of Nuclear Medicine, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada

Recent studies have shown that vasodilator-induced ischemic electrocardiographic (ECG) changes have incremental prognostic value over normal SPECT myocardial perfusion imaging (MPI) and identify patients at higher risk for cardiac events. The prognostic value of vasodilator-induced ischemic ECG changes in the setting of normal PET MPI has yet to be determined. We sought to determine the prognostic importance of dipyridamole-induced ischemic ECG changes in patients with normal 82Rb PET myocardial perfusion images. Methods: Between 2000 and 2003, 2,029 consecutive patients undergoing dipyridamole stress 82Rb PET at the University of Ottawa Heart Institute were evaluated. Patients with normal PET MPI and interpretable ECGs were enrolled. Electrocardiograms were assessed for ST depression or elevation and patients were categorized into those with and without dipyridamole-induced ischemic ECG changes. Images were graded using the 17-segment model. Follow-up information was obtained by telephone interview, from hospital records, or from treating physicians. All cardiac events (cardiac death, nonfatal myocardial infarction [MI], percutaneous coronary intervention, coronary artery bypass grafting, or angiography) were verified with hospital records. Results: Of the 629 enrolled patients with normal PET MPI, 72 patients had dipyridamole-induced ischemic ECG changes. There was no significant difference between the 2 groups in the combined endpoint (cardiac death, nonfatal MI, and revascularization) at follow-up (mean ± SD, 27.1 ± 13 mo). There were no cardiac deaths in either group. One (1.4%) patient with ischemic ECG changes had a nonfatal MI (0.6% annual event rate). Two (2.8%) patients with ischemic ECG changes required revascularization compared with 11 (2.0%) in the nonischemic ECG group. Conclusion: Normal 82Rb PET confers an excellent prognosis regardless of dipyridamole-induced ST depression.

Key Words: PET • dipyridamole • electrocardiogram • prognosis


Related articles in JNM:

THIS MONTH IN JNM

JNM 2005 46: 10a-11a. [Full Text]  



This article has been cited by other articles:


Home page
J Am Coll Cardiol ImgHome page
R. J. Gibbons and P. Chareonthaitawee
Establishing the Prognostic Value of Rb-82 PET Myocardial Perfusion Imaging: A Step in the Right Direction
J. Am. Coll. Cardiol. Img., July 1, 2009; 2(7): 855 - 857.
[Full Text] [PDF]


Home page
JNMHome page
K. L. Gould, T. Pan, C. Loghin, N. P. Johnson, and S. Sdringola
Reducing Radiation Dose in Rest-Stress Cardiac PET/CT by Single Poststress Cine CT for Attenuation Correction: Quantitative Validation
J. Nucl. Med., May 1, 2008; 49(5): 738 - 745.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
J Knuuti and F M Bengel
Positron emission tomography and molecular imaging
Heart, March 1, 2008; 94(3): 360 - 367.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
K. L. Gould, T. Pan, C. Loghin, N. P. Johnson, A. Guha, and S. Sdringola
Frequent Diagnostic Errors in Cardiac PET/CT Due to Misregistration of CT Attenuation and Emission PET Images: A Definitive Analysis of Causes, Consequences, and Corrections
J. Nucl. Med., July 1, 2007; 48(7): 1112 - 1121.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. J. Gibbons, P. A. Araoz, and E. E. Williamson
The Year in Cardiac Imaging
J. Am. Coll. Cardiol., December 5, 2006; 48(11): 2324 - 2339.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. Yoshinaga, B. J.W. Chow, K. Williams, L. Chen, R. A. deKemp, L. Garrard, A. Lok-Tin Szeto, M. Aung, R. A. Davies, T. D. Ruddy, et al.
What is the Prognostic Value of Myocardial Perfusion Imaging Using Rubidium-82 Positron Emission Tomography?
J. Am. Coll. Cardiol., September 5, 2006; 48(5): 1029 - 1039.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2005 by the Society of Nuclear Medicine.